The words “you have cancer” are life-changing for everyone impacted by a new diagnosis. AbbVie understands this, and that is why we have joined forces with leading global patient advocates to increase awareness about blood cancers.
Press Kit Items
Together with U.S. News and World Report we break down the basics of cancers that originate in the blood.
Sep 27, 2022
International organizations like Leukemia and Lymphoma Society (LLS), and Advanced Practitioner Society for Hematology and Oncology (APSHO) have dedicated decades to transforming the lives of patients, caregivers, and their loved ones by providing education, resources and support when patients need it most.
As part of our Blood Cancer Explained roundtable series, we were joined by these leading experts to discuss the complexities of blood cancer and explore how the blood cancer community can come together to continue to support patients to meet the needs of patients today and in the future.
Oct 05, 2022
In the second part of our video series, our partners from The Advanced Practitioner Society for Hematology and Oncology (APSHO) and the Leukemia and Lymphoma Society (LLS) return to discuss information about treatment options after a blood cancer diagnosis.
Oct 05, 2022
In the third and final part of our video series, our partners from The Advanced Practitioner Society for Hematology and Oncology (APSHO) and the Leukemia and Lymphoma Society (LLS) return to discuss how cancer research and new treatments are addressing unmet needs for patients diagnosed with rare or difficult-to-treat blood cancers.
100+ unique blood cancers exist and most fall under three main types: leukemia, lymphoma and myeloma. Learn more
Sep 27, 2022
An estimated 1.2 million blood cancer cases occur annually worldwide.
See how scientists have nearly doubled some survival rates in a generation, with even more scientific discoveries on the horizon.
On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.
Together with U.S. News and World Report we break down the basics of cancers that originate in the blood.
Sep 27, 2022
International organizations like Leukemia and Lymphoma Society (LLS), and Advanced Practitioner Society for Hematology and Oncology (APSHO) have dedicated decades to transforming the lives of patients, caregivers, and their loved ones by providing education, resources and support when patients need it most.
As part of our Blood Cancer Explained roundtable series, we were joined by these leading experts to discuss the complexities of blood cancer and explore how the blood cancer community can come together to continue to support patients to meet the needs of patients today and in the future.
Oct 05, 2022
In the second part of our video series, our partners from The Advanced Practitioner Society for Hematology and Oncology (APSHO) and the Leukemia and Lymphoma Society (LLS) return to discuss information about treatment options after a blood cancer diagnosis.
Oct 05, 2022
In the third and final part of our video series, our partners from The Advanced Practitioner Society for Hematology and Oncology (APSHO) and the Leukemia and Lymphoma Society (LLS) return to discuss how cancer research and new treatments are addressing unmet needs for patients diagnosed with rare or difficult-to-treat blood cancers.
100+ unique blood cancers exist and most fall under three main types: leukemia, lymphoma and myeloma. Learn more
Sep 27, 2022
An estimated 1.2 million blood cancer cases occur annually worldwide.
See how scientists have nearly doubled some survival rates in a generation, with even more scientific discoveries on the horizon.
On June 24, 2022, AbbVie shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs) in the U.S., which uncovered insights about the emotional journey associated with a CLL diagnosis.